SC 13G/A: MACROGENICS INC

AI Summary

SC 13G/A filing by MACROGENICS INC.

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.01 — of Securities: Common Stock, par value $0.01 per share 2(e) CUSIP Number: 55609910

Filing Documents

• d771056dsc13ga.htm (SC 13G/A) — 46KB
• 0001193125-24-032794.txt ( ) — 47KB

SIGNATURES

SIGNATURES After reasonable inquiry and the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BB Biotech AG Date: February 6, 2024 By: /s/ Martin Gubler Signatory Authority Name: Martin Gubler Title: Signatory Authority Date: February 6, 2024 By: /s/ Ivo Betschart Signatory Authority Name: Ivo Betschart Title: Signatory Authority Biotech Target N.V. Date: February 6, 2024 By: /s/ Jan Bootsma Signatory Authority Name: Jan Bootsma Title: Signatory Authority Date: February 6, 2024 By: /s/ Hugo van Neutegem Signatory Authority Name: Hugo van Neutegem Title: Signatory Authority 5 of 6 Exhibit Index Exhibit A: Agreement by and between BB Biotech AG and Biotech Target N.V. with respect to the filing of this disclosure statement.* * Previously filed as an exhibit to BB Biotech AG and Biotech Target N.V.s Schedule 13G filed with the Securities and Exchange Commission on December 29, 2016. 6 of 6